Reynold Spector Award in Clinical Pharmacology and Translational Medicine
The Reynold Spector Award honors major research achievements in clinical pharmacology and translational medicine that bridge laboratory science and clinical application, presented by the American Society for Pharmacology and Experimental Therapeutics.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates: September 21, 2026
Funding Amounts: Recognition award; typically includes a commemorative plaque and possible honorarium (see award page for details).
Summary: Honors outstanding achievements in clinical pharmacology and translational medicine, recognizing impactful work bridging research and clinical application.
Key Information: Intended for established investigators (typically age 45+); nomination required.
Description
This award recognizes individuals who have made significant contributions to the advancement of clinical pharmacology and translational medicine. It celebrates impactful work that bridges laboratory discoveries with clinical applications, highlighting research that leads to improved therapeutic outcomes and patient care. The Reynold Spector Award in Clinical Pharmacology and Translational Medicine is one of the major scientific achievement awards presented by the American Society for Pharmacology and Experimental Therapeutics (ASPET).
